FDA Warning on Xylazine: Mitigating Human Risk | by: Sumeet Singh, Founder & Chairman | Article Posted: November 6, 2023 | The U.S. Food and Drug Administration (FDA) has issued a warning regarding mitigating risks from human Xylazine exposure. FDA has not...
NY Pharmacies Unite to Take Aim at PBMs Originally published on Nov 29, 2018. Earlier this month over 500 independent pharmacy owners came together...
PBMs Turn Up Pressure on PSAOs Attacking the Last Line of Defense for Independent Pharmacy Recent industry events and further consolidation of the...
PBM Pressure: Politics, Prospects and Pass-Throughs Cigna & Express Scripts Follow Aetna & Caremark Lead for Fighting Chance It is no secret...
PBMs & the Continued Vertical Integration of the Pharmaceutical Supply Chain: A Visual Look at Recent Moves by CVS & Diplomat From...
